Q9Y618 (NCOR2_HUMAN) Homo sapiens (Human)
Nuclear receptor corepressor 2 UniProtKBInterProSTRINGInteractive Modelling
2514 aa; Sequence (Fasta) ; (Isoform 2; Isoform 4; Isoform 5; )
It is possible new templates exist for this target since these models were created.
Sequence Alignments
Experimental structures
| Description | Oligo-state | Ligands | Structure | Range |
|---|---|---|---|---|
| Structure of HDAC3 bound to corepressor and inositol tetraphosphate |
Heteromer O15379; | 1×ZN; 1×ACT; 2×K; 2×GOL; 1×I0P; | 4a69 | |
| Assess | ||||
| Co-ordinates and 1H, 13C and 15N chemical shift assignments for the complex of GPS2 53-90 and SMRT … |
Heteromer Q13227; | 2l5g | ||
| Assess | ||||
| Crystal structure of the human PPAR-alpha ligand-binding domain in complex with an antagonist GW647… |
Heteromer Q07869; | 1×471; | 1kkq | |
| Assess | ||||
| Crystal structure of the BCL6 BTB domain complexed with a SMRT co-repressor peptide |
Heteromer P41182; | 1r2b | ||
| Assess | ||||
| Crystal structure of RXRalpha ligand-binding domain complexed with corepressor SMRT2 |
Heteromer P19793; | 3r29 | ||
| Assess | ||||
| Crystal Structure of the mutant Human ROR gamma Ligand Binding Domain With rockogenin. |
Heteromer P51449; | 1×82R; | 5x8q | |
| Assess | ||||
| Ternary complex of Human ROR gamma Ligand Binding Domain With Compound T. |
Heteromer P51449; | 1×9P6; | 6a22 | |
| Assess | ||||
| Crystal structure of histone deacetylase 4 (HDAC4) in complex with a SMRT corepressor SP1 fragment |
Heteromer P56524; | 2×K; 2×ZN; | 5zoo | |
| Assess | ||||
| Discovery of the Second Generation ROR gamma Inhibitors Composed of an Azole Scaffold. |
Heteromer P51449; | 1×AYO; | 6ivx | |
| Assess | ||||
| Crystal structure of PPARgamma ligand binding domain in complex with SMRT peptide and inverse agoni… |
Heteromer P37231; | 2×EEY; | 6pdz | |
| Assess | ||||
| Crystal Structure of the mutant Human ROR gamma Ligand Binding Domain With Compound A. |
Heteromer G1RH57; | 1×82O; | 5x8x | |
| Assess | ||||
| Solution structure of the MYND domain from AML1-ETO complexed with SMRT, a corepressor |
Heteromer Q06455; | 2×ZN; | 2odd | |
| Assess | ||||
| Crystal structure of histone deacetylase 4 (HDAC4) in complex with a SMRT corepressor SP2 fragment |
Heteromer P56524; | 2×K; 2×ZN; | 5zop | |
| Assess | ||||
| Progesterone receptor with bound ulipristal acetate and a peptide from the co-repressor SMRT |
Heteromer P06401; | 1×2S0; | 4oar | |
| Assess | ||||
| Crystal structure of RXRalpha ligand-binding domain complexed with corepressor SMRT2 and antagonist… |
Heteromer P19793; | 2×RHN; | 3r2a | |
| Assess | ||||
| Structural insights into the recruitment of SMRT by the co-repressor SHARP under phosphorylative re… |
Heteromer Q96T58; | 2rt5 | ||
| Assess | ||||
| Solution structure of the SANT2 domain of the human nuclear receptor corepressor 2 (NCoR2), Northea… | monomer | 2ltp | ||
| Assess | ||||
| Solution Structure of the SMRT Deacetylase Activation Domain | monomer | 1xc5 | ||
| Assess | ||||
Homology models
| Oligo-state | QMEAN | Template | Range | Seq id (%) | Ligands |
|---|---|---|---|---|---|
| monomer | -1.66 | 6vyp.1.N | 34.48 | ||
| Assess | |||||
| monomer | -1.67 | 4czz.1.B | 30.84 | ||
| Assess | |||||
Homology models built on isoform sequence
| Isoform | Oligo-state | Ligands | QMEAN | Template | Range | Seq id (%) |
|---|---|---|---|---|---|---|
| Isoform 4 | monomer | -0.70 | 4a69.1.B | 100.00 | ||
| Assess | ||||||
| Isoform 4 | monomer | -0.40 | 2ltp.1.A | 98.25 | ||
| Assess | ||||||
| Isoform 4 | monomer | -5.51 | 1xc5.1.A | 100.00 | ||
| Assess | ||||||
| Isoform 4 | monomer | -1.66 | 6vyp.1.N | 34.48 | ||
| Assess | ||||||
| Isoform 4 | monomer | -1.67 | 4czz.1.B | 30.84 | ||
| Assess | ||||||
| Isoform 4 | monomer | 0.88 | 2l5g.1.B | 100.00 | ||
| Assess | ||||||
| Isoform 5 | monomer | -0.67 | 4a69.1.B | 100.00 | ||
| Assess | ||||||
| Isoform 5 | monomer | -0.49 | 2ltp.1.A | 98.57 | ||
| Assess | ||||||
| Isoform 5 | monomer | -5.50 | 1xc5.1.A | 100.00 | ||
| Assess | ||||||
| Isoform 5 | monomer | -1.58 | 6vyp.1.N | 34.48 | ||
| Assess | ||||||
| Isoform 5 | monomer | -1.66 | 4czz.1.B | 30.84 | ||
| Assess | ||||||
| Isoform 5 | monomer | 0.88 | 2l5g.1.B | 100.00 | ||
| Assess | ||||||